EFM
GPCR icon

E Fund Management’s Structure Therapeutics GPCR Stock Holding History

E Fund Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,589
Closed -$1.17M – 376
2023
Q4 		$1.17M Buy
+28,589
New +$1.64M 0.07% 82

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

E Fund Management's GPCR Position: Q1 2024 in Review

E Fund Management sold out of Structure Therapeutics (GPCR) in Q1 2024, closing a stake of 28,589 shares — an estimated $1.17M sold.

E Fund Management first reported a position in GPCR in Q4 2023 and held it in 1 quarter. The position peaked at $1.17M in Q4 2023. 119 funds tracked by Wall St. Rank hold GPCR as of Q1 2024.

  • E Fund Management reported no remaining Structure Therapeutics position as of Q1 2024 after selling out during the quarter.
  • E Fund Management sold 28,589 Structure Therapeutics shares in Q1 2024, an estimated $1.17M.
  • E Fund Management first reported a position in Structure Therapeutics in Q4 2023 and held it in 1 quarter.
  • E Fund Management's Structure Therapeutics position peaked at $1.17M in Q4 2023.
  • 119 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2024.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.